Relief from vascular occlusion using photothermal ablation of thrombus with a multimodal perspective
- 206 Downloads
Fibrinolytic therapy for arterial or venous thrombotic disorders involves the systemic administration of thrombolytics such as streptokinase, which is associated with serious bleeding complications. With this study, we provide a proof-of-concept of photothermal thrombus ablation with gold nanorods exposed to near-infrared irradiation, both in vitro using materials generated from purified fibrinogen or plasma and in vivo in murine blood vessels. This is the first report of the application of photothermal therapy as an anti-thrombotic measure. Remarkably, the addition of streptokinase had a multimodal additive effect with regard to acceleration of photothermal lysis of thrombi even at a dose significantly below the therapeutic concentration, thus minimizing the life-threatening side effects and adverse complications. This combinatorial approach exhibits great promise for lysing pathological clots while effectively overcoming the drawbacks of existing therapies.
Keywordsplatelet fibrin near-infrared laser photothermal therapy thrombolysis streptokinase
Unable to display preview. Download preview PDF.
- Canto, J. G.; Rogers, W. J.; Goldberg, R. J.; Peterson, E. D.; Wenger, N. K.; Vaccarino, V.; Kiefe, C. I.; Frederick, P. D.; Sopko, G.; Zheng, Z.-J. et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 2012, 307, 813–822.Google Scholar
- Weitz, J. I. Antiplatelet, anticoagulant, and fibrinolytic drugs. In Harrison’s Principles of Internal Medicine. Longo, D. L.; Fauci, A. S.; Kasper, D. L.; Hauser, S. L.; Jameson, J. L.; Loscalzo, J., Eds.; McGraw-Hill: New Delhi, 2011; Vol. 1, pp 1001–1003.Google Scholar
- Walters, M. I. An evaluation of hemoglobin concentrations obtained with frozen altered Drabkin’s reagents. Clin. Chem. 1968, 14, 682–691.Google Scholar
- Liopo, A.; Conjusteau, A.; Tsyboulski, D.; Ermolinsky, B.; Kazansky, A.; Oraevsky, A. Biocompatible gold nanorod conjugates for preclinical biomedical research. J. Nanomed. Nanotechnol. 2012, 6, 274.Google Scholar
- Kuo, W. T.; Odegaard, J. I.; Louie, J. D.; Sze, D. Y.; Unver, K.; Kothary, N.; Rosenberg, J. K.; Hovesepian, D. M.; Hwang, G. L.; Hofmann, L. V. Photothermal ablation with the excimer laser sheath technique for embedded inferior vena cava filter removal: Initial results from a prospective study. J. Vasc. Interv. Radiol. 2011, 22, 813–823.CrossRefGoogle Scholar
- Green, H. N.; Martyshkin, D. V.; Rodenburg, C. M.; Rosenthal, E. L.; Mirov, S. B. Gold nanorod bioconjugates for active tumor targeting and photothermal therapy. J. Nanotechnol. 2011, 2011, Article ID 631753.Google Scholar
- Betancourt, B. Y.; Marrero-Miragaya, M. A.; Jiménez-López, G.; Valenzuela-Silva, C.; García-Iglesias, E.; Hernández-Bernal, F.; Debesa-García, F.; González-López, T.; Alvarez-Falcón, L.; López-Saura, P. A. et al. Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction. BMC Clin. Pharmacol. 2005, 5, 5.CrossRefGoogle Scholar
- Kunitada, S.; FitzGerald, G. A.; Fitzgerald, D. J. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction. Blood 1992, 79, 1420–1427.Google Scholar